North America:
The North America insulin delivery devices market is highly developed, driven by a high prevalence of diabetes, advanced healthcare infrastructure, and significant investments in diabetes management technologies. The United States leads the market with widespread adoption of insulin pumps, continuous glucose monitors (CGMs), and smart insulin pens. The focus on...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian